MD — Pediatrix Medical Group, Inc. stock price, charts and financials

QT83Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. (NYSE: MD) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
24.71
-1.54-5.87%
MDQT83Pediatrix Medical Group, Inc.·NYSE
24.71-5.87%
Filing
Down 5.9% — Filed an 8-K material-event report (2026-08-04) — details in the filing.
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E12.05EPS (ttm)2.05Insider Own8.32%Shs Outstand82.12MPerf Week-8.00%
Market Cap2.03BForward P/E10.46EPS next Y2.36Insider Trans-0.53%Shs Float80.81MPerf Month-9.78%
Enterprise Value2.32BPEG-EPS next Q-Inst Own-Short Float6.07%Perf Quarter10.26%
Income175.00MP/S1.05EPS this Y11.35%Inst Trans-Short Ratio5.96Perf Half Y15.25%
Sales1.93BP/B2.31EPS next Y3.52%ROA8.42%Short Interest4.91MPerf YTD15.52%
Book/sh10.70P/C6.17EPS next 5Y-3.52%ROE20.09%52W High27.94 -11.56%Perf Year106.26%
Cash/sh4.01P/FCF9.16EPS past 3/5Y34.91% -ROIC9.59%52W Low11.90 107.65%Perf 3Y81.96%
Dividend Est.-EV/EBITDA8.34Sales past 3/5Y-0.99% 1.99%Gross Margin25.80%Volatility5.27% 3.96%Perf 5Y-15.09%
Dividend TTM-EV/Sales1.20EPS Y/Y TTM272.27%Oper. Margin11.86%ATR (14)1.09Perf 10Y-67.13%
Dividend Ex-Date-Quick Ratio1.33Sales Y/Y TTM-4.02%Profit Margin9.02%RSI (14)42.32Recom2.64
Dividend Gr. 3/5Y-Current Ratio1.33EPS Q/Q33.33%SMA20-5.29%Beta0.62Target Price24.60
Payout0.00%Debt/Eq0.76Sales Q/Q3.93%SMA500.37%Rel Volume1.84Prev Close26.25
Employees4,120LT Debt/Eq0.72EarningsNov 02SMA20011.40%Avg Volume834.70KPrice24.71
IPO DateSep 20, 1995Option/ShortYes / YesEPS/Sales Surpr.15.86% 2.23%Net Debt/EBITDA1.52Volume1,534,822Change-5.87%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-14-26ReiteratedTruist SecuritiesHold$21$28
May-12-26ReiteratedUBSNeutral$22$25
May-08-26ReiteratedMizuho SecuritiesNeutral$21$24
Apr-20-26ReiteratedJefferiesBuy$24$27
Feb-24-26ReiteratedUBSNeutral$23$22
Feb-20-26ReiteratedDeutsche BankHold$21$19
Nov-10-25ReiteratedTruist SecuritiesHold$17$24
Nov-05-25ReiteratedUBSNeutral$23
Oct-14-25ReiteratedTruist FinancialHold$16$17
Oct-07-24ReiteratedTruist SecuritiesHold$10$13
Latest News
Aug-04-26
Jul-24-26
Jul-21-26
Jul-17-26
Jul-16-26
Jul-15-26
Jul-14-26
Jul-03-26
Jun-23-26
Company

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,9321,9142,0131,9951,9721,9111,7341,7803,647
Cost of Goods Sold Incl. D&A1,4331,4421,5591,5731,5051,3981,2851,2772,658
Gross Profit498472454422467513449503990
Selling, General and Administrative Excl. Other243241238228231263249245432
Research and Development
000000000
Other Operating Expense260285186634710286112
Operating Income230231-69717320398172446
Interest Expense29364142406911011993
Unusual Expense
Non-Operating Income (Expense)28218-14-52119616
Net Income Before Taxes228216-101-4881135759369
Income Taxes5351-21219271717100
Consolidated Net Income175165-99-6066131-796-1,498269
Net Income From Continuing Operations175165-99-6063108-1042259
Net Income175165-99-6066131-796-1,498269
EPS (Recurring)2.061.94-1.19-0.720.801.52-9.31-17.782.95
EPS (Basic, Before Extraordinaries)2.061.94-1.19-0.720.801.52-9.31-17.782.95
EPS (Diluted)2.051.94-1.19-0.730.791.52-9.55-17.942.93
EBITDA278274-2830157236146204528
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio12.0511.0318.8117.9011.26
Price To Sales Ratio1.060.950.540.390.631.221.221.310.82
Gross Margin25.7824.6622.5521.1523.6826.8425.8928.2627.15
Operating Margin11.9012.07-3.430.358.7710.625.659.6612.23
Net Margin9.068.62-4.92-3.013.356.86-45.91-84.167.38
Shares Outstanding838583848386868491
Market Capitalization2,0511,8181,0897811,2332,3402,1102,3343,003
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$29.70$24.69$19.68$14.68$9.67 Close Price0.00K213.92K427.83K641.75K855.66KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Weis Shirley ADirectorMay 13 '26Sale23.7536,028855,6650May 14
ORDAN MARK SChief Executive OfficerDec 15 '25Sale22.4123,000515,430302,805Dec 17
Rucker Michael A.DirectorNov 17 '25Sale23.0010,478240,99459,101Nov 19
Linynsky Laura ADirectorNov 06 '25Sale21.6510,000216,50032,232Nov 10
ORDAN MARK SDirectorNov 13 '24Sale15.3527,600423,660138,683Nov 14
Moore Mary Ann EEVP, GC, Chief Admin Off & SecNov 08 '24Sale16.008,108129,728135,810Nov 12
Swift James DChief Executive OfficerAug 30 '24Sale10.7911,100119,769170,001Sep 03
Linynsky Laura ADirectorAug 27 '24Sale11.167,00078,12030,805Aug 29
Richards C MarcEVP, Chief Financial OfficerAug 12 '24Sale10.0817,438175,775175,347Aug 13
Richards C MarcEVP, Chief Financial OfficerAug 09 '24Sale10.0832,562328,225192,785Aug 13
Moore Mary Ann EEVP, General Counsel & SecDec 14 '23Sale9.622,12020,39415,730Dec 15
Swift James DChief Executive OfficerDec 14 '23Sale9.585,76455,21990,874Dec 15
Swift James DChief Executive OfficerJun 14 '23Sale14.1413,193186,54996,638Jun 16
ORDAN MARK SDirectorMay 25 '23Sale13.2633,000437,580147,923May 26
Weis Shirley ADirectorMay 19 '23Sale13.631,00713,72517,668May 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.